×

Connect us

Full Name:


Email:


Mobile:
+   -




Manufacturer of rAlblaz™

Recombinant Human Serum Albumin

A niche biotechnology company developing highly pure, animal-origin free, reagent and excipient grade rHSA, antigens & enzymes to cater to healthcare and biopharma industry across the globe.




Our Objective

Why Choose Us?

Improve Sustainability
World Class Bio-manufacturing

With a vision to "Make Lives Better" we are focused on improving human health by developing quality Biosimilars with the highest purity and providing them most economically to the Global market.

Improve Sustainability
Pharmaceutical excipient

Excipients are integral components of pharmaceutical products. Our excipient grade products are known to significantly improve the processability, performance, and stability associated with pharmaceutical processes.

Improve Sustainability
Global geographic reach

We believe to change global paradigm with our quality products. Our novel biotherapeutics aims to tap the global potential, to bring the best solution within reach of everyone at highly competitive prices.

Improve Sustainability
Reagent grade products

Our reagent grade products conform to the highest international standards. They are manufactured to suit the requirement of analytical, research laboratories, and manufacturing.

Applications

 

Safe

               

                   

Cell   Culture   Cryopreservation   Therapeutics & Vaccines  Resistant  Excipients   

Cell   Culture   Cryopreservation   Therapeutics & Vaccines Resistant   Excipients   

 

 IVF  Reagent   vaccines   Cryopreservation   Therapeutics    

 IVF   Reagent   vaccines   Cryopreservation   Therapeutics    

 IVF   Reagent   vaccines   Cryopreservation   Therapeutics    



Lazuline Biotech
Our flagship product

Recombinant Human Serum Albumin (rHSA), rAlblaz™

Lazuline Biotech is the first company in India involved in the production of rHSA and is one of the very few key players across the globe. With outstanding R&D team and innovative technology, we bring you our rHSA – a Pichia pastoris variant, highly pure, animal-origin free, consistent within all batches, and free of any endotoxins.

We accelerate innovation of superior quality biosimilars to accomplish our vision of "Making Lives Better"

Prasad Kandimalla
Co-founder and CEO
Our Products

We transform technological innovations into robust products

HCV Antigens
Agriculture industry

Worldwide, more than 200 million people are infected by the Hepatitis C virus (HCV). At least 50 million of these patients are potential targets of liver cirrhosis or cancer. Hepatitis C is mainly transmitted from person to person through blood contact. Therefore, almost every country has made it mandatory to screen blood donors for HCV. In order to produce a diagnostic kit, three to four of HCV antigens are used.

HIV Antigens
Minerals industry

With over 40 million infected people, AIDS is one of the worst humanitarian crises the world is facing. With no cure available, the most important step to combat this crisis is through prevention. The primary requirements for prevention are education and identifying the infected.

HBs Antigen
Pharma industry

HBsAg is the surface antigen of the hepatitis B virus (HBV). It indicates the current hepatitis B infection. The viral envelope of an enveloped virus has different surface proteins from the rest of the virus which acts as antigens. These antigens are recognized by antibody proteins that bind specifically to one of these surface proteins.

Enterokinase
Retail industry

Recombinant Enterokinase (rEK) is a highly purified enzyme manufactured by using Pichia Pastoris strain. Recombinant Enterokinase is a single glycosylated polypeptide chain containing 235 amino acids and having a molecular weight of ~43kDa. rEK recognizes the sequence Asp-Asp-Asp-Asp-Lys and cleaves the peptide bond after the lysine residue. One unit is defined as the amount of enzyme needed to cleave 50µg of a fusion protein in stipulated time and temperature conditions.

img/linkedin-blog-1.png
How can COVID-19 pandemic impact biosimilars
Article
https://www.linkedin.com/pulse/how-can-covid-19-pandemic-impact-biosimilars-kurapati-sandeep/
img/linkedin-blog-2.png
The Evolvement of Regulatory and Market Trends for Biosimilars
Article
https://www.linkedin.com/pulse/evolvement-regulatory-market-trends-biosimilars-lazuline-biotech/
img/linkedin-blog-3.png
Unlocking the potential of Pichia Pastoris expression system for rHSA
Article
https://www.linkedin.com/pulse/unlocking-potential-pichia-pastoris-expression-system-biotech/
img/linkedin-blog-4.png
How rHSA be a potential solution amid Corona outbreak for the Healthcare industry?
Article
https://www.linkedin.com/pulse/how-rhsa-potential-solution-amid-corona-outbreak-healthcare-khemu/

Fuel your growth with Lazuline to fuel your ambitions. Explore infinite opportunities at Lazuline